Axonics Modulation Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AXNX and buy or sell other stocks, ETFs, and their options commission-free!About AXNX
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women.
CEORaymond Wayne Cohen
CEORaymond Wayne Cohen
Employees—
Employees—
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2012
Founded2012
Employees—
Employees—
AXNX Key Statistics
Market cap3.63B
Market cap3.63B
Price-Earnings ratio-657.22
Price-Earnings ratio-657.22
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$71.05
52 Week high$71.05
52 Week low$55.09
52 Week low$55.09
Stock Snapshot
As of today, Axonics Modulation Technologies(AXNX) shares are valued at $70.98. The company's market cap stands at 3.63B, with a P/E ratio of -657.22.
During the trading day, Axonics Modulation Technologies(AXNX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0.
Over the past 52 weeks, Axonics Modulation Technologies(AXNX) stock has traded between a high of $71.05 and a low of $55.09.
Over the past 52 weeks, Axonics Modulation Technologies(AXNX) stock has traded between a high of $71.05 and a low of $55.09.
People also own
Based on the portfolios of people who own AXNX. This list is generated using Robinhood data, and it’s not a recommendation.